COSMO Pharmaceuticals SA (0RGI) — Cash Flow Quality Index
COSMO Pharmaceuticals SA (0RGI) has a Cash Flow Quality Index of 1.10x as of December 2024. Operating cash flow of £63.23 Million exceeds net income of £57.24 Million, indicating high earnings quality where cash backs reported profits. Explore COSMO Pharmaceuticals SA debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
COSMO Pharmaceuticals SA Cash Flow Quality Index (2005–2024)
Historical Cash Flow Quality Index for COSMO Pharmaceuticals SA across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see COSMO Pharmaceuticals SA cash flow conversion.
Annual Cash Flow Quality Index for COSMO Pharmaceuticals SA (2005–2024)
Year-by-year earnings quality comparison for COSMO Pharmaceuticals SA.
| Year | Quality Index | Operating CF (GBP) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.22x | £162.41 Million | £133.24 Million | ▼ -36.8% |
| 2022 | 1.93x | £32.89 Million | £17.05 Million | ▲ +231.5% |
| 2021 | 0.58x | £12.61 Million | £21.67 Million | ▼ -48.1% |
| 2016 | 1.12x | £21.69 Million | £19.34 Million | ▲ +809.1% |
| 2015 | -0.16x | £-39.26 Million | £248.19 Million | ▼ -117.5% |
| 2014 | 0.91x | £66.45 Million | £73.32 Million | ▲ +667.8% |
| 2013 | 0.12x | £8.11 Million | £68.73 Million | ▼ -90.1% |
| 2012 | 1.19x | £27.76 Million | £23.38 Million | ▼ -4.3% |
| 2011 | 1.24x | £11.29 Million | £9.09 Million | ▼ -28.9% |
| 2010 | 1.75x | £7.79 Million | £4.46 Million | ▲ +139.5% |
| 2009 | 0.73x | £3.88 Million | £5.32 Million | ▲ +154.8% |
| 2008 | -1.33x | £-12.52 Million | £9.40 Million | ▲ +93.9% |
| 2007 | -21.73x | £-2.52 Million | £116.00K | ▼ -387.1% |
| 2006 | 7.57x | £6.08 Million | £803.00K | ▲ +483.7% |
| 2005 | 1.30x | £1.70 Million | £1.31 Million | — |